Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...

First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing; Askle ...

The global smart wheelchair market is set for a period of significant expansion, with market projections indicating a striking increase from USD 185.7 million in 2024 to an estimated USD 393.5 million ...

The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...

the European Society for Paediatric Nephrology and patient advocates to support clinicians in the diagnosis, treatment and genetic counselling of children and adults with nephrogenic diabetes ...

The European Alliance of Associations for Rheumatology, in partnership with the Pediatric Rheumatology European Society (PReS ...

Fetal exposure to toxic metals in IUTs could be a significant public health concern, in particular for fetuses with HDFN, ...

The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), along with a growing number of endorsing medical ...

You’ll learn about current and future developments in paediatric molecular biology, learn to critically appraise basic and clinical science that underpins different treatments, and carry out your own ...

While these cities differ in architecture and atmosphere, both have been recognised for their smart travel initiatives, and have been named, respectively, the European Capital and Green Pioneer of ...